Sign up to our newsletter Subscribe
The Importance of Diversity of Supply in Rare Diseases Markets
External Expert Profile
Jake Hitch
Economist
Latest Publications
Supporting the Era of Green Pharmaceuticals in the UK
Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers
Read more
© Mayer Tawfik/Unsplash
The Lower Drug Costs Now Act and Pharmaceutical Innovation
